Hannans Reward Ltd (ASX:HNR) provides an update on its drilling program currently underway at the Jigalong Project, located in the South-East Pilbara region of Western Australia. Holes confirm shallow, laterally extensive Manganese mineralisation across the Hill 616 prospect that is open in both directions along strike. A diamond drilling program is now underway at the Hill 616 prospect to provide samples for the metallurgical beneficiation test work.
Biomedical company, Tissue Therapies Limited (ASX:TIS) says today that the VitroGro(R) synthetic protein has been classified as a biologic product by the US Food and Drug Administration (FDA). The FDA classification is consistent with the planned US clinical trials, manufacturing and sales launch of VitroGro(R) wound healing products. Meanwhile, the company has passed an EU audit and will shortly receive certificates necessary for the sale of VitroGro(R) wound healing products in the EU and Canada.
Navigator Resources Limited (ASX:NAV) has achieved the production milestone of 100,000 ounces of gold poured since the commencement of operation at the Company's Bronzewing Gold Project, located 960 kilometres northeast of Perth. The Company also continues to pursue development opportunities at the Leonora Gold Project, located 830 kilometres northeast of Perth, through a trial mining program and ongoing targeted exploration.
Tissue Therapies Limited
Navigator Resources Limited
Montezuma Mining Company Ltd
Hannans Reward Limited